STOCK TITAN

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

iCAD, Inc. (NASDAQ: ICAD) is scheduled to announce its financial results for Q4 and the year ending December 31, 2020, after market close on February 24, 2021. A conference call will take place at 4:30 PM ET, allowing investors to gain insights into the company's performance. The results are anticipated to highlight progress in iCAD's innovative cancer detection and therapy solutions. Interested parties can join the call via domestic and international numbers or through a webcast.

Loading...
Loading translation...
Argus Session date unavailable
+0.06% session move Open Argus
Details

News Market Reaction – ICAD

The recorded move for ICAD in the trading session of this news was +0.06%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NASHUA, N.H., Feb. 18, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2020, after the market close, and host a conference call at 4:30pm Eastern Time on Wednesday, February 24.

Wednesday February 24th @ 4:30pmET
Domestic: 877-407-0784
International: 201-689-8560
Conference ID: 13716857
Webcast: http://public.viavid.com/index.php?id=143673
   

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD  
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will iCAD release its Q4 2020 financial results?

iCAD will release its Q4 2020 financial results after market close on February 24, 2021.

What time is the iCAD conference call scheduled for?

The iCAD conference call is scheduled for 4:30 PM ET on February 24, 2021.

How can I join the iCAD conference call?

You can join the iCAD conference call by calling 877-407-0784 domestically or 201-689-8560 internationally.

Is there a webcast available for the iCAD conference call?

Yes, the iCAD conference call will be available via webcast at http://public.viavid.com/index.php?id=143673.

Keep reading